Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Revenue

Windlas Biotech had revenue of 2.68B INR in the quarter ending September 30, 2026, with 20.40% growth. This brings the company's total for the last twelve months to 9.93B, up 19.56% year-over-year. In the fiscal year ending March 31, 2026, Windlas Biotech had annual revenue of 9.04B with 18.98% growth. That makes Windlas Biotech the 22,245th largest company in the world by revenue and 1,333rd in India.

• Revenue (ttm): 9.93B
• Revenue Growth: +19.56%
• P/S Ratio: 2.10
• Revenue / Employee: 7.17M
• Employees: 1,385
• Market Cap: 21.05B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 8.52B 94.9%
• outside India 458.38M 5.1%

Fiscal year ended Mar 31, 2026 See the full Windlas Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	9.04B	1.44B	18.98%
Mar 31, 2025	7.60B	1.29B	20.43%
Mar 31, 2024	6.31B	1.18B	22.97%
Mar 31, 2023	5.13B	471.53M	10.12%
Mar 31, 2022	4.66B	383.28M	8.96%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error